REQUEST A DEMO
Total
USD $0.00
Search more companies

Pangen Biotech Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Pangen Biotech Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company primarily engaged in the bio pharmaceuticals development technology transfer services. The Company mainly provides contract services for the manufacture of bio pharmaceuticals, bio pharmaceuticals development technology transfer services for the manufacture of Chinese hamster ovary (CHO) cell lines and the process of products and gains royalty from the services. The Company also provides reagents which are used for the development of bio pharmaceuticals. In addition the Company is also engaged in the development of bio pharmaceuticals such as Biosimilar EPO, Recombinant Factor VIII and Biosimilar G-CSF. The Company provides its services within domestic market and to overseas markets such as China, India, Mexico, America and Europe. The Company was established on January 29, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on March 11, 2016.

Headquarters
4F, 2-Dong, 306, Sinwon-Ro, Yeongtong-Gu, Suwon-Si, Gyeonggi-Do
Suwon; Gyeonggi;

Contact Details: Purchase the Pangen Biotech Inc. report to view the information.

Website: http://www.pangen.com

Basic Information
Total Employees:
Purchase the Pangen Biotech Inc. report to view the information.
Outstanding Shares:
Purchase the Pangen Biotech Inc. report to view the information.
Registered Capital:
Purchase the Pangen Biotech Inc. report to view the information.
Financial Auditors:
Purchase the Pangen Biotech Inc. report to view the information.
Incorporation Date:
January 29, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
12.9%
Purchase this report to view the information.
9.4%
Purchase this report to view the information.
8.4%
Subsidiaries
(주)팬젠
Company Performance
Financial values in the chart are available after Pangen Biotech Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
12.53%
Total operating revenue
12.56%
Operating profit (EBIT)
8.34%
EBITDA
12.46%
Net Profit (Loss) for the Period
0.11%
Total assets
0.33%
Total equity
-27.02%
Operating Profit Margin (ROS)
13.01%
Net Profit Margin
7.77%
Return on Equity (ROE)
-9.62%
Debt to Equity Ratio
16.03%
Quick Ratio
-1.21%
Cash Ratio
-0.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?